Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results
Organogenesis | S-3: Registration statement for specified transactions by certain issuers
Organogenesis | 8-K: Current report
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
Organogenesis | DEF 14A: Definitive information statements
Organogenesis | 8-K: Current report
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance
Organogenesis | 8-K: Current report
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results
Organogenesis | DEF 14A: Definitive proxy statements
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Fourth Quarter 2022and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance
Organogenesis | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Third Quarter 2022 Financial Results
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results
Organogenesis | 8-K: Current report
Organogenesis | DEF 14A: Definitive proxy statements
Organogenesis | 8-K: Organogenesis Holdings Inc. Reports First Quarter 2022 Financial Results
Organogenesis | 8-K: Current report
No Data
No Data